Healthcare provider profile · identity verified

Melissa A Payne, MD

Family Practice · DELAWARE, OH · NPI 1902847742

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	378	127
Levothyroxine Sodium	Levothyroxine Sodium	230	73
Gabapentin	Gabapentin	175	55
Lisinopril	Lisinopril	168	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	144	26
Pantoprazole Sodium	Pantoprazole Sodium	140	50
Amlodipine Besylate	Amlodipine Besylate	138	47
Alprazolam	Alprazolam	133	22
Tramadol Hcl	Tramadol Hcl	132	24
Omeprazole	Omeprazole	120	46
Hydrochlorothiazide	Hydrochlorothiazide	111	34
Losartan Potassium	Losartan Potassium	101	35
Albuterol Sulfate Hfa	Albuterol Sulfate	99	40
Trazodone Hcl	Trazodone Hcl	89	30
Clonazepam	Clonazepam	88	13
Rosuvastatin Calcium	Rosuvastatin Calcium	81	30
Metformin Hcl	Metformin Hcl	75	29
Alendronate Sodium	Alendronate Sodium	71	19
Tizanidine Hcl	Tizanidine Hcl	70	20
Metoprolol Succinate	Metoprolol Succinate	68	29
Oxycodone Hcl	Oxycodone Hcl	68	suppressed
Clopidogrel	Clopidogrel Bisulfate	67	22
Atenolol	Atenolol	66	19
Tamsulosin Hcl	Tamsulosin Hcl	66	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	17
Metoprolol Tartrate	Metoprolol Tartrate	65	16
Meloxicam	Meloxicam	62	22
Escitalopram Oxalate	Escitalopram Oxalate	61	19
Furosemide	Furosemide	59	20
Montelukast Sodium	Montelukast Sodium	56	16
Simvastatin	Simvastatin	56	17
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	55	17
Buspirone Hcl	Buspirone Hcl	51	22
Glimepiride	Glimepiride	49	17
Mirtazapine	Mirtazapine	47	16
Citalopram Hbr	Citalopram Hydrobromide	45	17
Duloxetine Hcl	Duloxetine Hcl	44	14
Clonidine Hcl	Clonidine Hcl	41	11
Eliquis	Apixaban	41	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Sertraline Hcl	Sertraline Hcl	41	18
Prednisone	Prednisone	40	30
Azithromycin	Azithromycin	37	33
Warfarin Sodium	Warfarin Sodium	37	11
Carvedilol	Carvedilol	36	13
Lorazepam	Lorazepam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	34	suppressed
Celecoxib	Celecoxib	32	suppressed
Cephalexin	Cephalexin	32	26
Metformin Hcl Er	Metformin Hcl	32	12
Ondansetron Hcl	Ondansetron Hcl	32	16
Allopurinol	Allopurinol	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	15
Spiriva Respimat	Tiotropium Bromide	31	suppressed
Famotidine	Famotidine	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	30	suppressed
Bupropion Xl	Bupropion Hcl	29	12
Butalb-Acetaminoph-Caff-Codein	Butalbit/Acetamin/Caff/Codeine	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	11
Fluticasone Propionate	Fluticasone Propionate	27	11
Spironolactone	Spironolactone	27	suppressed
Eszopiclone	Eszopiclone	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	12
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Naproxen	Naproxen	23	suppressed
Ezetimibe	Ezetimibe	22	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Pregabalin	Pregabalin	20	11
Valacyclovir	Valacyclovir Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Hydroxyzine Hcl	Hydroxyzine Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Cefdinir	Cefdinir	15	12
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Finasteride	Finasteride	15	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Invokana	Canagliflozin	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Ramipril	Ramipril	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Clonidine	Clonidine	11	suppressed
Estradiol	Estradiol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Midodrine Hcl	Midodrine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error